An online lifestyle modification course for people with multiple sclerosis: a randomised controlled trial of course effectiveness.

Brief summary of clinical study

Lifestyle factors are known to affect the progression of multiple sclerosis (MS). The Multiple Sclerosis Online Course (MSOC) has been developed to deliver a widely accessible and user-friendly educational tool regarding modification of lifestyle related risk factors for people with MS.
The intervention consists of arms: 1. an MS Online intervention course based delivering evidence-based information regarding modifiable lifestyle related risk factors implicated in disease progression; and 2. an MS Online standard-care course, similar in format and presentation, but containing general information sourced from standard MS websites. Both courses have seven modules delivered over six weeks. Having conducted a feasibility study, (ACTRN12621000245897) the purpose of this study is to test the effectiveness of the intervention course compared with the standard-care arm in a larger randomised controlled trial.

The study hypothesis is that undertaking an MS Online Course delivering evidence based information regarding the modification of lifestyle related risk factors will lead to changed behaviours and improved health outcomes for people with MS.

If you have diagnosed MS and seek evidence-based information about MS & lifestyle, join this free & flexible 6-week online course dedicated to increasing knowledge & improving health/wellbeing of people living with MS around the world!

Course duration: 24 July to 3 Sep 2023.

Estimated effort: 1-2 hr per week

Cost fee: Free

Content: Introduction to MS, diet, Vitamin D, exercise, mindfulness, medication, pregnancy, family & prevention.

Eligibility: Adults with diagnosed Multiple Sclerosis (MS)

Level: Introductory

Find out more about the Multiple Sclerosis Online Course here:


Contact the research team at
Trial Information:
Trial Status: recruiting
Date Registered: December 27, 2021
Ethics Application Status: submitted
Anticipated date of first participant enrollment: 22/06/2023
Anticipated date of last participant enrollment: 30/12/2023
Are Healthy Volunteers able to participate? no
Key Inclusion Criteria:

Inclusion criteria for this clinical trial:

1. Be able to read, write, and speak English;
2. Be 18 years old or over;
3. Have a confirmed diagnosis of relapsing-remitting MS (by a neurologist);
4. Be able to access the internet and be able to view sessions

Key Exclusion Criteria:


Gender: Male & Female
Minimum Age: 18 year(s)
Other Information:

Recruitment outside Australia – YES

Country [1] Canada
State/province [1] All
Country [2] New Zealand
State/province [2] All
Country [3] United Kingdom
State/province [3] All
Country [4] United States Of America
State/province [4] All


Clinical Trial Recruitment Contacts

Assoc. Prof. Sandra Neate
Neuroepidemiology Unit
Centre for Epidemiology and Biostatistics
Melbourne School of Population and Global Health
Level 3, 207 Bouverie Street Carlton
The University of Melbourne, Victoria 3010 Australia
Contact us to take part in this clinical research study: